These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8071858

  • 1. 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo.
    Wilkinson LO, Middlemiss DN, Hutson PH.
    J Pharmacol Exp Ther; 1994 Aug; 270(2):656-64. PubMed ID: 8071858
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats.
    Fujii T, Nakai K, Nakajima Y, Kawashima K.
    Can J Physiol Pharmacol; 2000 May; 78(5):392-9. PubMed ID: 10841434
    [Abstract] [Full Text] [Related]

  • 8. Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats.
    Winsauer PJ, Rodriguez FH, Cha AE, Moerschbaecher JM.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):335-47. PubMed ID: 9862788
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K, Fujii T, Fujimoto K, Suzuki T, Kawashima K.
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [Abstract] [Full Text] [Related]

  • 11. Effects of 8-OH-DPAT on hippocampal NADH fluorescence in vivo in anaesthetized rats.
    Rex A, Fink H.
    J Neurosci Res; 2006 Mar; 83(4):551-6. PubMed ID: 16435395
    [Abstract] [Full Text] [Related]

  • 12. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB, Ravailhe V, Faucillon V, Newman-Tancredi A.
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis.
    Fujii T, Yoshizawa M, Nakai K, Fujimoto K, Suzuki T, Kawashima K.
    Brain Res; 1997 Jul 04; 761(2):244-9. PubMed ID: 9252022
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
    Kleven MS, Koek W.
    J Pharmacol Exp Ther; 1996 Feb 04; 276(2):388-97. PubMed ID: 8632301
    [Abstract] [Full Text] [Related]

  • 15. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 04; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 16. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat.
    Schreiber R, de Vry J.
    J Pharmacol Exp Ther; 1993 May 04; 265(2):572-9. PubMed ID: 8496807
    [Abstract] [Full Text] [Related]

  • 17. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
    O'Neill MF, Sanger GJ.
    Eur J Pharmacol; 1999 Apr 09; 370(2):85-92. PubMed ID: 10323255
    [Abstract] [Full Text] [Related]

  • 18. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Chojnacka-Wójcik E.
    Pol J Pharmacol Pharm; 1992 Apr 09; 44(2):135-46. PubMed ID: 1357637
    [Abstract] [Full Text] [Related]

  • 19. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E, Filip M, Bijak M, Wedzony K, Budziszewska B, Tokarski K, Maćkowiak M, Fijał K.
    Pol J Pharmacol; 1996 Apr 09; 48(1):13-22. PubMed ID: 9112623
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct 09; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.